Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07077746
Recruiting
HB-adMSCs for the Treatment of Crohn's Disease
Phase 2 · United States · 1 site
Registry update: 6 Aug 2026
NCT07281768
Recruiting
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Phase 2 · United States · 1 site
Registry update: 21 Jul 2026
NCT07650773
Recruiting
CHARM Hepatocellular Carcinoma MEA Study
Not applicable · United Arab Emirates, Egypt, Kuwait, Morocco, Qatar, Saudi Arabia · 17 sites
Registry update: 14 Oct 2026
NCT07652242
Recruiting
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
Phase 1 · United States · 2 sites
Registry update: 10 Sept 2026
NCT07741383
Recruiting
A Study on the Efficacy and Safety of TEER Combined With Electrical Cardioversion in Patients With Severe Mitral Regurgitation and Atrial Fibrillation
Not applicable · China · 1 site
Registry update: 3 Aug 2026
NCT07682961
Recruiting
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Phase 3 · Australia, Japan, United States · 19 sites
Registry update: 14 Aug 2026
NCT07609862
Recruiting
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
Phase 1/2 · China · 1 site
Registry update: 30 Jul 2026
NCT07579754
Recruiting
BetterInfo on Women's PrEP Choices and Outcomes in Malawi
Not applicable · Malawi · 1 site
Registry update: 15 Jul 2026
NCT07816835
Recruiting
Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
Phase 4 · United States · 2 sites
Registry update: 14 Sept 2026
NCT07688551
Recruiting
Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation
Phase 2/3 · United States · 3 sites
Registry update: 21 Jul 2026
NCT07287202
Recruiting
Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)
Phase 1/2 · Australia · 2 sites
Registry update: 10 Aug 2026
NCT07708064
Recruiting
Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
Not applicable · United States · 1 site
Registry update: 11 Aug 2026
NCT07599410
Recruiting
A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
Phase 2 · China · 2 sites
Registry update: 23 Jul 2026
NCT07466316
Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Phase 3 · Canada, United States · 87 sites
Registry update: 25 Aug 2026
NCT07824050
Recruiting
Analysis of Life-threatening ARrhythMias After Acute Coronary Syndrome
Not applicable · Netherlands · 1 site
Registry update: 13 Oct 2026
NCT07628140
Recruiting
Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission
Not applicable · Kenya · 1 site
Registry update: 27 Aug 2026
NCT07802678
Recruiting
Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors
Phase 4 · Netherlands · 4 sites
Registry update: 3 Sept 2026
NCT07237308
Recruiting
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
Phase 4 · South Korea · 1 site
Registry update: 16 Oct 2026
NCT07579884
Recruiting
To Evaluate the Safety and Efficacy of RP902 Tablets
Phase 2 · China · 2 sites
Registry update: 1 Oct 2026
NCT07512271
Recruiting
Generative AI Patient Education Module for Breast Oncology
Not applicable · United States · 1 site
Registry update: 6 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.